Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Ali Rafaqat, Muhammad Irfan Sattar, Muhammad Hafeez and Muhammad Farrukh Shahzad
Objectives: To determine the effectiveness of interferential current on overactive bladder syndrome. Methodology: It is a quasi-experimental study. The duration of the study is 8 weeks. Total 40 patients were selected for this experimental study from Benazir Bhutto Hospital (BBH) Rawalpindi Pakistan. Sample was drawn through non-probability sampling technique called simple convenient sampling. Standard questionnaire was used for measurement through which results were calculated. Complete information about the patients including their biodata, symptomatology was entered in a Performa and then data was entered on the basis of Overactive Bladder Symptom Score (OABSS) scoring system. A total of 40 patients between the age of 5 to 12 years of age with no gender, religion, or ethnic background differentiation and with the diagnosis of overactive bladder were included. Results: it showed that baseline Mean pyuria was 1.75 ± 0.493 SD and after treatment 1.25 ± 0.439 SD and dysuria baseline mean is 1.78 ± 0.474 SD and after treatment Mean is 1.32 ± 0.423 SD. Hematuria baseline mean is 1.98 ± 0.423 SD and after treatment mean is 1.78 ± 0.158 SD mean frequency of urination is 2.0 ± 0.234 and after treatment mean is 1.2 ± 0.342 bed wetting mean is 1.62 ± 0.423 SD and after treatment mean is 1.22 ± 0.490 SD OABSS Score mean is 2.125 ± 0.334 SD and after treatment mean is 1.55 ± 0.597 SD all values showed significant difference. Conclusion: Interferential Current (IFC) Therapy is a very effective and beneficial tool to improve the symptoms and quality of life of the patients with Hinman syndrome.